Call for Abstract

World Drug Delivery Summit, will be organized around the theme “Emerging Interventions and Cutting Edge Drug Delivery Technology”

Drug Delivery 2015 is comprised of 10 tracks and 59 sessions designed to offer comprehensive sessions that address current issues in Drug Delivery 2015.

Submit your abstract to any of the mentioned tracks. All related abstracts are accepted.

Register now for the conference by choosing an appropriate package suitable to you.

  • Track 1-1Noval drug delivery system
  • Track 1-2Polymers to enhance drug delivery
  • Track 1-3Invitro & invivo studies
  • Track 1-4Improvement of dissolution rate
  • Track 1-5ADME analysis and toxicity studies
  • Track 1-6Targeted drug delivery
  • Track 1-7Pharmacokinetic behaviour in drug design and development
  • Track 2-1Novel routes for drug delivery
  • Track 2-2Topical Drug Delivery
  • Track 2-3Advances and new technology in insulin delivery
  • Track 2-4Pulmonary Mode of Drug Delivery
  • Track 2-5Skin Permeation Route
  • Track 3-1novel pharmaceutical ingredients
  • Track 3-2pH and Environmental sensitive
  • Track 3-3Carriers for Nanotech
  • Track 3-4new biodegradable polymers
  • Track 3-5Delivery through Versatile polymers
  • Track 4-1Current advances in nanotechh
  • Track 4-2Mesoporous silica nanoparticles
  • Track 4-3Delivery of nano particles
  • Track 4-4Nano crystals for Drug Delivery
  • Track 4-5Challenges and advances in nanotechnology
  • Track 4-6Future aspects of nanotechnologies
  • Track 5-1Immunostimulatory systems
  • Track 5-2Advances in Vaccine Drug Delivery
  • Track 5-3laser technology for Vaccine Delivery
  • Track 5-4Challenges and opportunities For Vaccine Delivery
  • Track 5-5Jet injectors and microneedles
  • Track 5-6Needle-free delivery
  • Track 5-7Vaccines for cancer chemotherapy
  • Track 6-1Biotherapeutics formulations
  • Track 6-2Rheological behaviour
  • Track 6-3Industry perspective
  • Track 6-4Stability of Pharmaceutical products
  • Track 6-5Advances in computational modeling for bioavailability.
  • Track 7-1Emerging Medical Devices
  • Track 7-2surgical sutures
  • Track 7-3Contact Lenses
  • Track 7-4wireless MEMS
  • Track 7-5smart polymers in medical devices
  • Track 7-6Medical device biocompatibility evaluation
  • Track 7-7Microfibricated and microfluidic devices
  • Track 8-1Formulation strategies for solid pharmaceutical dosage forms
  • Track 8-2Characterisation techniques to improve drug bioavailability¬†
  • Track 8-3Novel advances in cns targeted drug delivery
  • Track 8-4 Tumor targeting and future for cancer biomarkers
  • Track 8-5Biopolymers, coatings and bioabsorbable intelligent materials
  • Track 8-6Pro-drugs as novel drug delivery systems
  • Track 9-1Reducing Patient Compliance
  • Track 9-2Challenges for Drug Delivery of poorly soluble drugs
  • Track 9-3Advances in self-emulsifying drug delivery systems (SEDDS)
  • Track 9-4Overcoming challenges in pediatric drug delivery
  • Track 9-5Controlling the addictive nature of drugs
  • Track 9-6Polymeric enhancement
  • Track 10-1Consistent quality and competitive costs of product
  • Track 10-2Production performance and continuity of supply
  • Track 10-3Product and technology auditing and due diligence
  • Track 10-4Regulatory Issues, quality control, and business development
  • Track 10-5Bussiness opportunities in drug delivery